RankAlpha logo
Back to Rankings

AURA

Aura BiosciencesC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
AURA vs peer average
49/100
AURA vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 3 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

XFOR is the first available peer comparator.

Small-cap clinical biotech where valuation depends heavily on milestone timing, readout credibility, and financing durability; useful as an event-risk comparator despite different disease focus.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerXFORX4
AURA
Aura Biosciences
XFOR
X4
Grade
C
A
Momentum
48
19
Value
41
41
Sentiment
70
98
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs XFOR

AURA / XFOR
Grade Position
In line
AURA vs. peer average (C vs. C)
49/100
Momentum
48
AURA
Value
41
AURA
Sentiment
70
XFOR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AURA
1
XFOR
XFOR
A
100/100
-2
2
RLMD
RLMD
C
60/100
Even
3
PALI
PALI
C
60/100
Even
4
RIGL
Rigel Pharmaceuticals Inc Common
A
100/100
-2
5
MNPR
Monopar Therapeutics Inc Common
B
80/100
-1
XFOR is the first peer returned for this comparison set.